9781107405806

Progress in Neurotherapeutics and Neuropsychopharmacology

by
  • ISBN13:

    9781107405806

  • ISBN10:

    1107405807

  • Format: Paperback
  • Copyright: 2012-07-26
  • Publisher: Cambridge Univ Pr
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $79.00 Save up to $11.85
  • Buy New
    $67.15
    Add to Cart Free Shipping

    SPECIAL ORDER: 1-2 WEEKS

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

Summary

Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.

Table of Contents

Progress in Neurotherapeutics and Neuropsychopharmacology 2007
A randomized trial comparing unilateral pallidotomy with bilateral subthalamic nucleus stimulation in PD: perspectives for future implication in clinical practice
The phase II futility clinical trial design
Clinical trials in dementia
Comparative neuropsychological effects of Lamotrigine and Topiramate in healthy volunteers
Pilot clinical trial of NT-3 in CMT1A patients
New directions in pediatric neuro-oncology practice: impact of the Children's Cancer Group Study 9933, a phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma
Chemoradiotherapy for primary CNS lymphoma
A double-blind, randomized clinical trial to assess the augmentation with Nimodipine of antidepressant therapy in the treatment of 'vascular depression'
Repetitive transcranial magnetic stimulation: a novel, noninvasive add-on treatment for medication-resistant depression
The NIMH MATRICS initiative: development of a consensus cognitive battery
Review of a randomized controlled trial of adjunctive Bupropion in the treatment of SSRI-induced sexual dysfunction
Trial-based advances in the treatment of bipolar depression
Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of Risperidone monotherapy
Olanzapine as maintenance therapy in patients with bipolar I disorder
Can quality of life be improved in schizophrenia? Results from a pragmatic, randomized controlled trial comparing Olanzapine with first generation antipsychotics
Combined behavioral and pharmacological treatment of opioid-dependent adolescents: a randomized, controlled trial
Table of Contents provided by Publisher. All Rights Reserved.

Rewards Program

Write a Review